Loading
Latest filing published 16 Jul 2020 for Brainstorm Cell Therapeutics INC., €57k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Setboun is a declared insider of Brainstorm Cell Therapeutics Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 7 April 2020 to 16 July 2020, the count stands at 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €57k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
On 16 July 2020 came the latest disclosure, an open-market purchase for €57k in Brainstorm Cell Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations